Monitoring Atypical Metabolite Biomarkers in Patients with Bile Acid Synthesis Disorders by a Novel Targeted Tandem Mass Spectrometry Assay.

Setchell KDR, Zhao X, Reed S, Zhang W

Open source

DOI
10.3390/metabo16070436
Published
2026 Jun 23
Container
Metabolites
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/metabo16070436,
  title = {Monitoring Atypical Metabolite Biomarkers in Patients with Bile Acid Synthesis Disorders by a Novel Targeted Tandem Mass Spectrometry Assay.},
  author = {Setchell KDR and Zhao X and Reed S and Zhang W},
  year = {2026},
  journal = {Metabolites},
  doi = {10.3390/metabo16070436},
  url = {https://doi.org/10.3390/metabo16070436}
}

RIS

TY  - JOUR
TI  - Monitoring Atypical Metabolite Biomarkers in Patients with Bile Acid Synthesis Disorders by a Novel Targeted Tandem Mass Spectrometry Assay.
AU  - Setchell KDR
AU  - Zhao X
AU  - Reed S
AU  - Zhang W
PY  - 2026
JO  - Metabolites
DO  - 10.3390/metabo16070436
UR  - https://doi.org/10.3390/metabo16070436
ER  - 

APA

KDR, S., X, Z., S, R., & W, Z. (2026). Monitoring Atypical Metabolite Biomarkers in Patients with Bile Acid Synthesis Disorders by a Novel Targeted Tandem Mass Spectrometry Assay.. Metabolites. https://doi.org/10.3390/metabo16070436

Source records